spacer
spacer

PDBsum entry 1j4l

Go to PDB code: 
Top Page protein ligands links
Transferase PDB id
1j4l
Contents
Protein chain
158 a.a.
Ligands
GLU-VAL-GLU-LEU-
TPO-GLN-GLU-LEU-
PRO

References listed in PDB file
Key reference
Title Solution structure of the yeast rad53 fha2 complexed with a phosphothreonine peptide ptxxl: comparison with the structures of fha2-Pyxl and fha1-Ptxxd complexes.
Authors I.J.Byeon, S.Yongkiettrakul, M.D.Tsai.
Ref. J Mol Biol, 2001, 314, 577-588. [DOI no: 10.1006/jmbi.2001.5141]
PubMed id 11846568
Abstract
It was proposed previously that the FHA2 domain of the yeast protein kinase Rad53 has dual specificity toward pY and pT peptides. The consensus sequences of pY peptides for binding to FHA2, as well as the solution structures of free FHA2 and FHA2 complex with a pY peptide derived from Rad9, have been obtained previously. We now report the use of a pT library to screen for binding of pT peptides with the FHA2 domain. The results show that FHA2 binds favorably to pT peptides with Ile at the +3 position. We then searched the Rad9 sequences with a pTXXI/L motif, and tested the binding affinity of FHA2 toward ten pT peptides derived from Rad9. One of the peptides, (599)EVEL(pT)QELP(607), displayed the best binding affinity (K(d)=12.9 microM) and the greatest chemical shift changes. The structure of the FHA2 complex with this peptide was then determined by solution NMR and the structure of the complex between FHA2 and the pY peptide (826)EDI(pY)YLD(832) was further refined. Structural comparison of these two complexes indicates that the Leu residue at the +3 position in the pT peptide and that at the +2 position in the pY peptide occupy a very similar position relative to the binding site residues from FHA2. This can explain why FHA2 is able to bind both pT and pY peptides. This position change from +3 to +2 could be the consequence of the size difference between Thr and Tyr. Further insight into the structural basis of ligand specificity of FHA domains was obtained by comparing the structures of the FHA2-pTXXL complex obtained in this work and the FHA1-pTXXD complex reported in the accompanying paper.
Figure 5.
Figure 5. Structures of (a) the FHA2-pT peptide complex and (b) the FHA2-pY peptide complex. FHA2 is shown in ribbons and the peptides are shown as sticks. The side-chains of (a) pT and (b) pY are colored magenta, and those of Leu at (a) +3 and at (b) +2 are colored green. The minimized mean structures are used.
Figure 7.
Figure 7. Diagrams showing detailed interactions between the phosphopeptide and the protein in (a) the FHA2-pT peptide complex and (b) the FHA2-pY peptide complex. Possible hydrogen bonds are defined as for Figure 6 and shown as dotted lines. Intermolecular NOEs are shown as double-pointed arrows, where thick and thin lines indicate strong and medium-sized NOEs, respectively. Highly conserved residues are colored cyan. The intramolecular hydrogen bond between Arg617 and Asp683 is also predicted and is shown with a question mark because the distance between donor and acceptor heavy atoms is somewhat larger than the definition: (a) 4.6 Å in the pT complex and (b) 4.8 Å in the pY complex.
The above figures are reprinted by permission from Elsevier: J Mol Biol (2001, 314, 577-588) copyright 2001.
Secondary reference #1
Title Ii. Structure and specificity of the interaction between the fha2 domain of rad53 and phosphotyrosyl peptides.
Authors P.Wang, I.J.Byeon, H.Liao, K.D.Beebe, S.Yongkiettrakul, D.Pei, M.D.Tsai.
Ref. J Mol Biol, 2000, 302, 927-940. [DOI no: 10.1006/jmbi.2000.4095]
PubMed id 10993733
Full text Abstract
Figure 5.
Figure 5. The binding interface for FHA2 and the Rad9 pTyr peptide (a) Surface representation of the FHA2 domain in complex with the peptide; (b) side-chain interactions of the peptide with the FHA2 domain. The backbone ribbons of FHA2 and the peptide are shown in purple and green, respectively. The side-chains of FHA2 and the peptide are shown in red and yellow, respectively. MOLMOL [Koradi et al 1996] and Insight II (Molecular Simulations Inc.) were used for (a) and (b), respectively.
Figure 6.
Figure 6. Schematic ribbon diagrams of the FHA2-Rad9 pTyr peptide and the SH2-pTyr peptide [Eck et al 1993] complex structures. The pTyr binding sites are also shown. The Figure was generated using MOLSCRIPT [Kraulis 1991].
The above figures are reproduced from the cited reference with permission from Elsevier
Secondary reference #2
Title Structure and function of a new phosphopeptide-Binding domain containing the fha2 of rad53.
Authors H.Liao, I.J.Byeon, M.D.Tsai.
Ref. J Mol Biol, 1999, 294, 1041-1049. [DOI no: 10.1006/jmbi.1999.3313]
PubMed id 10588905
Full text Abstract
Figure 1.
Figure 1. (a) Sequence alignments of FHA motifs. The first two lines are for FHA2 and FHA1, respectively, of Rad53. (b) Sequence of the FHA2-containing domain of Rad53 (residues 573 to 730). The secondary structures were identified based on the NMR data.
Figure 6.
Figure 6. Comparison of the potential phosphate binding site of FHA2 with that of SH2 domain (Eck et al., 1993) and 14-3-3 protein (Yaffe et al., 1997).
The above figures are reproduced from the cited reference with permission from Elsevier
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer